Comparison of Results from Inpatient and Outpatient Treatment of Tuberculosis in Republic of Macedonia by Simonovska, Ljiljana & Ilievska-Popovska, Biljana
 _______________________________________________________________________________________________________________________________ 
OA Maced J Med Sci. 2015 Jun 15; 3(2):337-340.                                                                                                                                                                         337 
 
 
ID Design 2012/DOOEL Skopje 
Open Access Macedonian Journal of Medical Sciences. 2015 Jun 15; 3(2):337-340. 
http://dx.doi.org/10.3889/oamjms.2015.050 
Public Health 
  
 
 
Comparison of Results from Inpatient and Outpatient Treatment 
of Tuberculosis in Republic of Macedonia  
 
 
Ljiljana Simonovska
*
, Biljana Ilievska-Popovska  
 
Institute for Lung Diseases and Tuberculosis, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje, 
Republic of Macedonia 
 
 
Citation: Simonovska Lj, Ilievska-Popovska B. 
Comparison of Results from Inpatient and Outpatient 
Treatment of Tuberculosis in Republic of Macedonia. OA 
Maced J Med Sci. 2015 Jun 15; 3(2):337-340. 
http://dx.doi.org/10.3889/oamjms.2015.050 
Key words: tuberculosis; outcome; sputum conversion; 
cured; died; Republic of Macedonia. 
*
Correspondence: Prof. Dr. Ljiljana Simonovska. Institute 
for Lung Diseases and Tuberculosis, Department for Lung 
diseases, st. Majka Tereza No. 17, 1000 Skopje, Republic 
of Macedonia. E-Mail: damjanovska25@hotmail.com 
Received: 30-Mar-2015; Revised: 22-Apr-2015; 
Accepted: 23-Apr-2015; Online first: 30-Apr-2015 
Copyright: © 2015 Ljiljana Simonovska, Biljana Ilievska-
Popovska. This is an open access article distributed under 
the terms of the Creative Commons Attribution License, 
which permits unrestricted use, distribution, and 
reproduction in any medium, provided the original author 
and source are credited. 
Competing Interests: The authors have declared that no 
competing interests exist. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract  
BACKGROUND: The successful treatment of patients with active tuberculosis is one of the 
priorities in the Tuberculosis Control Programs. 
AIM: The aim was to establish whether there was a statistically significant difference in the 
treatment outcome in patients with tuberculosis who began their initial treatment phase and/or 
pursued it as inpatient, as opposed to patients with tuberculosis who underwent their entire 
treatment regime as outpatient. Moreover, our goal was to determine whether there is a statistically 
significant difference in the outcome from the treatment between patients with tuberculosis who 
were hospitalized up to one month, two months, or more than two months. 
MATERIALS AND METHOD: The study includes 355 patients, divided into two groups. The first 
group, which consists of 219 patients, began their initial treatment phase as inpatient, and then they 
continued the treatment as outpatient. The second group, 136 patients, underwent their entire 
treatment as outpatient. The treatment outcome is determined with every patient (cured, treatment 
completed, treatment default, treatment failed, died, treatment in progress). For the statistical data 
analysis and for establishing the significance of the findings regarding the differences between the 
two groups we used the Pearson Chi-Square Test and the Yates Corrected Test. 
RESULTS: The statistical analysis with the Pearson Chi-Square Test showed that the treatment 
outcome does not significantly depend on the model of treatment (p = 0.31). The statistical data 
analysis showed that there is no statistically significant difference in the achievement of conversion 
of the bacterial result of the sputum at the end of the initial phase of treatment regarding the studied 
groups (p = 0.89). The statistical data analysis showed that the length of inpatient treatment affects 
the outcome of the treatment and that the difference is statistically highly significant (p < 0.00005). 
CONCLUSION: There are no statistically significant differences in the sputum conversion and the 
treatment outcome among inpatient/outpatient with tuberculosis or outpatient only; however, the 
length of inpatient treatment is statistically significant regarding its effect on the treatment outcome. 
 
 
 
Introduction 
 
The successful treatment of patients with 
active tuberculosis is one of the priorities in the 
Tuberculosis Control Programs. The treatment 
guidelines suggest the target of 85% successfully 
treated cases of tuberculosis. In 1994 the World 
Health Organization made an estimation of the rate of 
success regarding the treated patients, which showed 
that results vary: a 77% success rate where the 
directly observed therapy (DOT) is used and only 41% 
in countries where DOT is not used. 
 In terms of the inpatient treatment, there are 
no conclusive findings on whether it gets better results 
in patients with tuberculosis [1]. According to 
numerous studies there is higher risk of intrahospital 
transmission of the infection [2], and also cause a 
greater socio-economic loss in patients and their 
families [3-6]. 
 The American Thoracic Society recommends 
that priority be given to the outpatient treatment model 
for treatment of patients with tuberculosis, and that the 
infectiveness does not constitute a reason for 
hospitalization [4]. The same recommendation is 
given by the World Health Organization (WHO). 
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According to Caminero [7], reasons for hospitalization 
are: poor physical condition, complications associated 
with tuberculosis, drug’s side effects, social reasons, 
and application of second line anti TB- medication.  
There are studies regarding the patients with 
multi-drug-resistant tuberculosis (MDR-TB). During 
their case revision regarding patients with MDR-TB 
who were inpatient or outpatient, Bassili and his 
associates [8] came to the conclusion that there is not 
a single category in terms of the outcome (successful 
treatment, failed treatment, stopped treatment or 
death) where the treatment model played any role 
 The aim was to establish whether there was a 
statistically significant difference in the treatment 
outcome in patients with tuberculosis who began their 
initial treatment phase and/or pursued it as inpatient, 
as opposed to patients with tuberculosis who 
underwent their entire treatment regime as outpatient. 
Moreover, our goal was to determine whether there is 
a statistically significant difference in the outcome 
from the treatment between patients with tuberculosis 
who were hospitalized up to one month, two months, 
or more than two months. 
 
 
Material and Methods 
 
The study includes 355 patients, who were 
treated from tuberculosis, in 2012.  
The patients were divided into two groups. 
The first group, which consists of 219 patients, began 
their initial treatment as inpatient, and then they 
continued the treatment as outpatient. The second 
group, 136 patients, underwent their entire treatment 
as outpatient. 
Criteria for inclusion in the research were: All 
new and previously treated patients with pulmonary 
and extrapulmonary tuberculosis, who have received 
their results from the treatment. Criteria for exclusion 
from the research were: All new and previously 
treated patients with pulmonary and extrapulmonary 
tuberculosis, who have not received their results from 
the treatment. All patients were treated by essential 
anti-tuberculosis medication 
The treatment outcome is determined with 
every patient according treatment outcome definitions 
recommended by WHO and National TB strategy 
(cured, treatment completed, treatment default, 
treatment failed, died, treatment in progress). For the 
statistical data analysis and for establishing the 
significance of the findings regarding the differences 
between the two groups we used the Pearson Chi-
Square Test and the Yates Corrected Test. 
 
Results 
 
Table 1 shows distribution of patients with 
tuberculosis according to age.  
Table 1: Distribution of patients with tuberculosis according to 
age 
Age 
Groups 
0-14 15-24 25-34 35-44 45-54 55-64 >65 Total 
Number of 
patients 
29 
(8.16%) 
59 
(16.61%) 
54 
(15.21%) 
51 
(14.36%) 
60 
(16.90%) 
44 
(12.39%) 
58 
(16.33%) 
355 
(100%) 
 
According to gender, 214 (60.28 %) were 
males, and 141 (39.71 %) were females; a scale of 
1.5:1 (M:F). 
Table 2: Distribution of the treatment outcome according to the 
model of treatment 
Treatment outcome  
Model of treatment 
Total Outpatient 
treatment 
Inpatient/outpatient 
treatment 
Cured 50 (38.76%) 79 (36.07%) 129 
Treatment Completed 66 (48.53%) 96 (43.84%) 162 
Treatment default 6 (4.41%) 10 (4.57%) 16 
Treatment failed 1 (0.74%) 2 (0.91%) 3 
Died 5 (3.68%) 23 (10.5%) 28 
Treatment in progress 8 (5.88%) 9 (4.11%) 17 
Total 136 219 355 
Pearson Chi-square: 5.95, df=5, p=0.31. 
 
Table 2 shows the distribution of the 
treatment outcome (cured, treatment completed, 
treatment default, treatment failed, died, treatment in 
progress) according to the model of treatment. The 
statistical analysis with the Pearson Chi-Square Test 
showed that the treatment outcome does not 
significantly depend on the model of treatment (p = 
0.31). 
The statistical data analysis showed that there 
is no statistically significant difference in the 
achievement of conversion of the bacterial result at 
the end of the second month for the new cases, and 
the end of the third month for the previously treated 
cases, that are at the end of the initial phase of 
treatment regarding the group of inpatient/outpatient 
and the group of outpatient only (p = 0.89). 
The results of achievement of conversion of 
the bacterial results at the end of the second and the 
third month according to the model of treatment are 
shown in Table 3.  
Table 3: Achievement of conversion of the bacterial results at 
the end of the second and the third month according to the 
model of treatment 
Microscopy results at 
the end of 2/3 month 
Model of treatment Total 
Outpatient treatment Inpatient/outpatient 
treatment 
Negative 56 (96.55%) 86 (95.56%) 142 
Positive 2 (3.45%) 4 (4.44%) 6 
Total 58 90 148 
Yates corrected = 0.02, df=1, p=0.89. 
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The statistical data analysis showed that the 
length of the inpatient treatment affects the outcome 
of the treatment and that the difference is statistically 
highly significant (p < 0.00005). The results are shown 
in Table 4. 
Table 4: Distribution of the treatment outcome according to the 
length of inpatient treatment 
Treatment outcome Length of treatment Total 
1-30 days 30-60 days Над 60 days 
Cured 13 (18,57%) 25 (32.89%) 41(56.16%) 79 
Treatment completed 41(58.57%) 36 (47.37%) 19(26.03%) 96 
Treatment default 4 (5.71%) 4 (5.26%) 2 (2.74%) 10 
Treatment failed 1 (1.43%) 1 (1.32%) 0 2 
Dead 11 (15.71%) 8 (10.53%) 4 (5.48%) 23 
Treatment in progress 0 2 (2.63%) 7 (9.59%) 9 
Total 70 76 73 219 
Pearson Chi-square: 37.29, df=10, p=0.00005. 
 
 
Discussion 
 
The successful treatment of patients with 
active tuberculosis is one of the priorities in the 
Tuberculosis Control Programs. The treatment 
guidelines suggest the target of 85% successfully 
treated cases of tuberculosis.  
 In terms of the inpatient treatment, there are 
no conclusive findings of whether it gets better results 
in patients with tuberculosis [1]. 
In our retrospective study which includes 355 
patients, out of which 136 (38.3%) were outpatient 
during the two phases of the therapy regime, and 219 
(61.2%) were inpatient and outpatient, the statistical 
analysis with the Pearson Chi-Square Test showed 
that the tuberculosis treatment outcome does not 
significantly depend on the model (manner) of 
treatment (p = 0.31). 
 The statistical data analysis using the Yates 
Corrected Test showed that there is not a significant 
difference in the achievement of conversion in the 
bacterial result, as a criterion for the treatment 
success at the end of the initial phase of the treatment 
in the group of outpatient compared to the group of 
inpatient/outpatient (p = 0.89).  
The statistical treatment outcome data 
analysis using the Pearson Chi-Square Test in 
patients with different lengths of inpatient treatment in 
this research (during the period of up to one, two or 
more than two months) showed that the length of the 
inpatient treatment statistically had a significant 
impact on the results of the treatment ( р < 0.00005). 
The best treatment outcome was recognized 
in patients who received the longest inpatient 
treatment, i.e. longer than two months. 56% of the 
patients were cured, which can be attributed to the 
fact that the tuberculosis patients are a 
heterogeneous group of patients. Often there are 
grave forms of tuberculosis with present risk factors 
(alcoholism, drug addiction), or the patients fall under 
different categories, often followed by comorbid 
conditions, such as: diabetes, psychiatric disorders, 
cardiomiopathy, bronchitis, and a possible present 
resistance which is not the subject of this research. All 
these factors condition the length of the inpatient 
treatment in some patients (longer than two months) 
so that they could get the best therapy response.  
 The treatment completed as an outcome 
which is statistically significant usually is present in 
the group of inpatient treated up to one month. This 
outcome is common in patients who are smear 
negative, or have extrapulmonary tuberculosis. Since 
it is a case of smear negative tuberculosis, the one-
month inpatient treatment is regarded as a sufficiently 
long period in order to achieve satisfactory results in 
this category of patients. Or, perhaps this category 
should be treated as outpatient only.  
 According to the statistical data analysis, the 
number of "treatment default" was not enormous 
(10/219), but the break in treatment most often 
happened to patient who was hospitalized for one or 
two months, and they cut the treatment after they 
leave the hospital during the therapy regime. Perhaps 
they had not understood seriously the 
recommendation to take their medications regularly. 
Perhaps they have returned to their old habits. 
Nevertheless, the breaks in treatment are reasons for 
the appearance of a resistant form of tuberculosis, 
and it is necessary to make efforts to reduce the 
number of these patients to a minimum.  
Although the number of inpatient whose 
treatment failed is very small, still that number is 
statistically bigger among the patients who were 
treated in hospital up to two months compared to 
patients who were treated more than two months. 
Some of the predictive factors include the bad 
cooperation, i.e. the irregular medicine intake after the 
inpatient treatment.  
According to Wobeser [1], causes for 
treatment failure are: alcoholism, drug abuse, and the 
possible drug resistance which is not a subject of this 
research. 
 In this study we have come to a realization 
that in 10% (23/219) of the inpatient, the result is 
death. However, according to the statistical data 
analysis using the Pearson Chi-Square Test it is 
concluded that statistically death occurs most often in 
cases where the inpatient treatment lasted up to one 
month. 
In the study by Perrechi [9], which included 
474 patients, out of which 166 continued the treatment 
as inpatient and 308 as outpatient, it was concluded 
that the death rate in the inpatient was statistically 
higher (23.5%) compared to the death rate in 
outpatient (2.6%). By using a multivariate analysis it 
was shown that the hospitalization of the patients was 
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associated with grave forms of tuberculosis.  
 Our analysis also showed that the statistically 
most significant death rate in patients who were 
treated for up to one month is due to predictive factors 
like the grave forms of tuberculosis, comorbid 
conditions, risk factors, such as alcoholism, which 
causes weakening of the non specific immunity, and 
the toxic hepatitis, which initiates a change in the 
therapy regimes, i.e. a usage of less hepatotoxic 
drugs, but also less effective therapy regimes.  
 According to Wobeser [6] some of the 
predictive mortality factors are: patients older than 50, 
immunosuppressant therapy, HIV, manifestation of 
drug’s side effects and the present antituberculosis 
drugs resistance.  
The “treatment in progress” as a treatment 
outcome in this research is present in a small number 
of cases among the inpatient/outpatient (9/219). 
However, this treatment outcome is statistically more 
present in patients who were hospitalized longer than 
two months. These patients receive an individual 
treatment regime which depends on various allergic 
and toxic manifestations. The individual regimes 
usually include less effective antituberculosis drugs, 
and that prolongs the treatment. The weaker therapy 
response and the presence of toxic and allergic 
manifestations are independent predictive factors for 
the prolongation of the hospital and the overall 
treatment in separate tuberculosis cases.  
 The analysis brings us to the conclusion that 
there are no statistically significant differences in the 
sputum conversion and the treatment outcome among 
patients with tuberculosis who were treated as 
inpatient/outpatient or as outpatient only; however, the 
length of the inpatient treatment is statistically 
significant regarding its effect on the treatment 
outcome. 
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